National Diagnostic Reference Level (DRL) for nuclear medicine computed tomography-positron emission tomography hybrid imaging studies for kuwait population: second phase dose audit-2019

Affiliations

24 November 2021

-

doi: 10.1259/bjro.20210020


Abstract

Objective: Diagnostic reference levels (DRLs) for CT part of positron emission tomography-CT (PET-CT) examinations are limited. The study was aiming to execute the second phase of the national DRL in support of optimisation and dose reduction in State of KW.

Methods: In this multicentre collaborative PET-CT study, oncology patient data were exclusively collected due to the National MOH Ethical Committee recommendation and limitation of the other studies. Median, Mean, SD, 75th, 25th percentiles as well as whole body (WB) effective dose (ED) were calculated. The study was UK-IPEM-based methodology and it was the second phase of the study in Kuwait.

Results: Half body (HB) and WB scans were 65 and 35% of the total enterers (309). The third quartile dose-length product (DLP) (mGy x cm) and volumetric CT dose index (mGy) values for the HB (537, 5) were higher than the UK NDRL (400, 4.3) but were lower than the Swiss NDRL (620, 6) and the France NDRL (762, 7.7). Comparatively, the proposed NDRLs for the WB (684, 4.1) were lower than Swiss National Data (720, 5.0) though, the Swiss had about 5000 (HB) & 706 (WB), the UK had 370 (HB) and France had 1000 (HB) entries. Calculated ED varied from 4.1 to 10.2 mSv, (mean values = 6.9 mSv) for HB and from 2.6 to 7 mSv (mean value = 4.6 mSv).

Conclusions: There was 9.1% improvement in NDRL for 2019, compared to 2018, but there is a continuous need for improving NDRL.

Advances in knowledge: Data provided a trend of NDRL that is served as a national data bank for continuous optimisation.


References

 

  1. Masoomi M, Al-Shammeri J, Al-Shammeri I, Elrahman H, Bashir M, Bradley D. Establishment of National DRL for CT in hybrid imaging studies – “The First National NM CT (PET) dose audit for KW population. International, Journal of Recent Scientific Research 2019; 46: S835–6.
  2. Jallow N, Christian P, Sunderland J, Graham M, Hoffman JM, Nye JA. Diagnostic reference levels of CT radiation dose in whole-body PET/CT. J Nucl Med 2016; 57: 238–41. doi: 10.2967/jnumed.115.160465 - DOI - PubMed
  3. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, et al. . A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41: 1369–79. - PubMed
  4. von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology 2006; 238: 405–22. doi: 10.1148/radiol.2382041977 - DOI - PubMed
  5. Kinahan PE, Townsend DW, Beyer T, Sashin D. Attenuation correction for a combined 3D PET/CT scanner. Med Phys 1998; 25: 2046–53. doi: 10.1118/1.598392 - DOI - PubMed
  6. Radiation dose to patients from radiopharmaceuticals: addendum 3 to ICRP publication 53—ICRP publication 106. Ann ICRP 2008; 38: 1–2. - PubMed
  7. Graham MM, Badawi RD, Wahl RL. Variations in PET/CT methodology for oncologic imaging at U.S. academic medical centers: an imaging response assessment team survey. J Nucl Med 2011; 52: 311–7. doi: 10.2967/jnumed.109.074104 - DOI - PMC - PubMed
  8. Wu T-H, Chu T-C, Huang Y-H, Chen L-K, Mok S-P, Lee J-K, et al. . A positron emission tomography/computed tomography (PET/CT) acquisition protocol for CT radiation dose optimization. Nucl Med Commun 2005; 26: 323–30. doi: 10.1097/00006231-200504000-00004 - DOI - PubMed
  9. ICRP. Recommendations of the International Commission on radiological protection. ICRP publication 60. 1990, ANN. ICRP 1991; 21(1–3). - PubMed
  10. ICRP. Radiological protection and safety in medicine. ICRP publication 73. Ann ICRP 26.
  11. International Atomic Energy Agency (IAEA). Radiation protection of patients, diagnostic reference levels (DRLs) in CT. 2019. Available from: https://www.iaea.org/resources/rpop/health-professionals/radiology.
  12. Institute of Physics and Engineering in Medicine (IPEM) .Guidance on the establishment and use of diagnostic reference levels for medical X-ray examinations. IPEM; report 88; 2004.
  13. Iball GR, Bebbington NA, Burniston M, Edyvean S, Fraser L, Julyan P, et al. . A national survey of computed tomography doses in hybrid PET-CT and SPECT-CT examinations in the UK. Nucl Med Commun 2017; 38: 459–70. doi: 10.1097/MNM.0000000000000672 - DOI - PubMed
  14. Lima TVM, Gnesin S, Ryckx N, Strobel K, Stritt N, Linder L. Swiss survey on hybrid imaging CTs doses in Nuclear Medicine and proposed national dose reference levels “On behalf of the Swiss Workgroup on Nuclear Medicine DRLs. Z Med Phys 2017; 28: 265–75. - PubMed
  15. Etard C, Celier D, Roch P, Aubert B. National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011. Institute de radioprotection et de Suˆ rete´ Nucle´aire (IRSN), PRP-HOM/SER/UEM, bp 17, 92262 Fontenay-Aux-Roses, France. Radiation Protection Dosimetry 2012; 152: 334–8. - PubMed
  16. IAEA .Radiation protection of patients (RPOP) – diagnostic reference levels (DRLs) in medical imaging. Vienna: IAEA; 2016.
  17. Söderberg M, Gunnarsson M. Automatic exposure control in computed tomography--an evaluation of systems from different manufacturers. Acta Radiol 2010; 51: 625–34. doi: 10.3109/02841851003698206 - DOI - PubMed
  18. Lee CH, Goo JM, Ye HJ, Ye S-J, Park CM, Chun EJ, et al. . Radiation dose modulation techniques in the multidetector CT era: from basics to practice. Radiographics 2008; 28: 1451–9. doi: 10.1148/rg.285075075 - DOI - PubMed
  19. Kalra MK, Maher MM, Toth TL, Schmidt B, Westerman BL, Morgan HT, et al. . Techniques and applications of automatic tube current modulation for CT. Radiology 2004; 233: 649–57. doi: 10.1148/radiol.2333031150 - DOI - PubMed
  20. Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, et al. . Fdg PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 2015; 42: 328–54. doi: 10.1007/s00259-014-2961-x - DOI - PMC - PubMed
  21. Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, et al. . Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med 2006; 47: 885–95. - PubMed
  22. Seong J-H, Park S-K, Kim J-S, Jung W-Y, Kim H-S, Dong K-R, et al. . A comparative study on the CT effective dose for various positions of the patient’s arm. Journal of the Korean Physical Society 2012; 61: 1137–42. doi: 10.3938/jkps.61.1137 - DOI
  23. International Commission on Radiological Protection. Diagnostic reference levels in medical imaging: review and additional advice. A web module produced by Committee 3 of the International Commission on Radiological Protection (ICRP). 2019. Available from: http://www.icrp.org/docs/DRL_for_web.pdf.
  24. Shrimpton PC, Jansen JTM, Harrison JD. Updated estimates of typical effective doses for common CT examinations in the UK following the 2011 national review. Br J Radiol 2016; 89: 20150346. doi: 10.1259/bjr.20150346 - DOI - PMC - PubMed
  25. International Commission on Radiological Protection Adult reference computational phantoms. ICRP publication 110. Ann ICRP 2009; 39: 1–164. - PubMed
  26. Shrimpton PC. Assessment of patient dose in CT. NRPB-PE/1/2004. Chilton, NRPB. Also published as Appendix C of the 2004 CT quality criteria. 2004. Available from: http://www.biophysicssite.com/Documents/NRPB_W67/NRPB_W67.pdf.
  27. Tonkopi E, Ross AA, MacDonald A. Journal Club: CT dose optimization for whole-body PET/CT examinations. AJR Am J Roentgenol 2013; 201: 257–63. doi: 10.2214/AJR.12.10495 - DOI - PubMed
  28. Inoue Y, Nagahara K, Tanaka Y, Miyatake H, Hata H, Hara T. Methods of CT dose estimation in whole-body ¹⁸F-FDG PET/CT. J Nucl Med 2015; 56: 695–700. doi: 10.2967/jnumed.114.153718 - DOI - PubMed